Related Experiment Video
Updated: Sep 25, 2025
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel
Chiara Tortora1, Alessandra Di Paola2, Mara Creoli2
1Department of Woman, Child and General and Specialist Surgery, University of Campania "Luigi Vanvitelli," Naples, Italy.
Insights
Targeting cannabinoid receptor type 2 (CB2) and transient receptor potential vanilloid type-1 (TRPV1) may help treat osteoporosis in pediatric inflammatory bowel diseases (IBD). Stimulating these receptors reduces osteoclast overactivity and modulates iron metabolism.
Area of Science:
- Bone Biology
- Inflammatory Bowel Disease Pathogenesis
- Metabolic Bone Diseases
Background:
- Inflammatory bowel diseases (IBD) are linked to reduced bone mineral density and osteoporosis.
- Dysregulated iron metabolism in IBD causes iron deficiency and intracellular iron overload.
- Iron overload accelerates osteoclast differentiation and activity, promoting bone resorption.
Purpose of the Study:
- To investigate the roles of CB2 and TRPV1 receptors in pediatric IBD-associated osteoporosis.
- To assess the impact of iron metabolism on osteoclast activity in IBD.
- To explore the therapeutic potential of modulating CB2 and TRPV1 in IBD osteoporosis.
Main Methods:
- Osteoclasts (OCs) were differentiated from IBD patients and healthy donors.
- Evaluated CB2 and TRPV1 receptor expression, OC activity, and iron metabolism.
- Assessed the effects of pharmacological modulation of CB2 and TRPV1 on OC activity and iron metabolism.
Main Results:
- Confirmed the roles of CB2 and TRPV1 in bone metabolism.
- Demonstrated that iron overload enhances osteoclast overactivity.
- Showed that stimulating CB2 and TRPV1 receptors reduces iron-induced OC overactivity.
Conclusions:
- CB2 and TRPV1 receptor stimulation can mitigate IBD-related osteoporosis.
- These receptors exert direct effects on osteoclast activity.
- Modulating CB2 and TRPV1 influences iron metabolism, contributing to osteoporosis treatment.
Background:
The reduction of bone mineral density and osteoporosis have high impacts on the health of patients with inflammatory bowel diseases (IBD). We have previously shown that a dysregulated iron metabolism occurs in IBD and leads to a decrease in circulating iron concentration and excessive intracellular sequestration of iron. Studies suggest that iron overload significantly affects the bone, accelerating osteoclast (OC) differentiation and activation, promoting bone resorption. Moreover, we demonstrated that iron overload causes OC overactivity. The cannabinoid receptor type 2 (CB2) and the transient receptor potential vanilloid type-1 (TRPV1) are potential therapeutic targets for bone diseases. The aim of this study was to evaluate the roles of CB2 and TRPV1 receptors and of iron in the development of osteoporosis in pediatric IBD.
Methods:
We differentiated OCs from peripheral blood mononuclear cells of patients with IBD and healthy donors and evaluated CB2 and TRPV1 receptor expression; OC activity, and iron metabolism by Western blot, TRAP assays, bone resorption assays, and iron assays. Moreover, we analyzed the effects of the pharmacological modulation of CB2 and TRPV1 receptors on OC activity and on the iron metabolism.
Results:
We confirmed the well-known roles of CB2 and TRPV1 receptors in bone metabolism and suggested that their stimulation can reduce the OC overactivity induced by iron, providing new insights into the pathogenesis of pediatric IBD-related bone resorption.
Conclusions:
Stimulation of CB2 and TRPV1 could reduce IBD-related osteoporosis due to their direct effects on OC activity and to modulating the iron metabolism.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...